Cellutech Pharma Private Limited - Due diligence report

A 360° intelligence report on Cellutech Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2022-01-25 Hyderabad, Telangana Active Unlisted
Share
Connect MCP
CP Cellutech Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Cellutech Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
59/100
Trust Score
Moderate

Cellutech Pharma Private Limited is assessed as Moderate with a Trust Score of 59/100. Cellutech Pharma Private Limited is an active private limited indian non-government company incorporated in 2022, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 11 Aug 2026 from the latest processed filings. Cellutech Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
30/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 1 open (16.50 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 30/100
NameDIN / PANDesignationAppointedTenureDIN status
Dheer Shreyas Sanghavi 01234567 Director 01/04/2018 6 yrs Approved
MANAN SANGHAVI 01234567 Director 01/04/2018 6 yrs Approved
BIJAL SANDEEP SANGHAVI 01234567 Director 01/04/2018 6 yrs Approved
SNEHAL SANGHAVI SHREYAS 01234567 Director 01/04/2018 6 yrs Approved
SANDEEP DILIP SANGHAVI 01234567 Director 01/04/2018 6 yrs Approved
SHREYASH DILIP SANGHAVI 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • BIJAL SANDEEP SANGHAVI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 4 director exits in 3 years - high churn.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Young company (4 years).
Active EPFO - real payroll on record.
Distress signals & risk flags
3 director exits within 2 years.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 16.50 cr already registered.
  • Compliance record supports lending.
Investor view18/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 14 events
05 Dec 2025
Director appointed
BIJAL SANDEEP SANGHAVI (Additional Director)
Director appointed
SNEHAL SANGHAVI SHREYAS (Additional Director)
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
19 Sep 2024
Director ceased
Dheer Shreyas Sanghavi
14 Sep 2024
Director appointed
Dheer Shreyas Sanghavi (Director)
Director ceased
PARTH ANIL SANGHAVI
Director ceased
MANISH SASHIKANT SANGHAVI
29 Sep 2023
Director ceased
MANAN SANGHAVI
20 Jul 2023
Charge created
Hdfc Bank Limited - 16.50 cr
17 Feb 2023
Director appointed
MANAN SANGHAVI (Director)
25 Jan 2022
Incorporated
Registered with Roc Hyderabad
Director appointed
SANDEEP DILIP SANGHAVI (Director)
Director appointed
SHREYASH DILIP SANGHAVI (Director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
Peer companies will appear here as our matching engine processes this industry.
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Cellutech Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Cellutech Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Cellutech Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Cellutech Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Cellutech Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Cellutech Pharma Private Limited an active company?

Cellutech Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Cellutech Pharma Private Limited financially healthy?

Cellutech Pharma Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Cellutech Pharma Private Limited?

Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Cellutech Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 6 active director(s) are on record.

Does Cellutech Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Cellutech Pharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Cellutech Pharma Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.